Sruthi L. Muluk

Sruthi L. Muluk

Auto-generated profile, based on publicly available information

Sruthi L. Muluk

University of Pittsburgh School of Medicine, Pittsburgh, PA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2022 in Health Services Research
Verified
Journal Article
Closed access
SMSruthi Muluk
Sruthi Muluk
LSLindsay Sabik
Lindsay Sabik
QCQingwen Chen
Qingwen Chen
BJBruce Jacobs
Bruce Jacobs
ZSZhaojun Sun
Zhaojun Sun
CDColeman Drake
Coleman Drake

23 March 2023 in Journal of General Internal Medicine
Verified
Journal Article
Closed access
PDF file
SMSruthi L. Muluk
Sruthi L. Muluk
GLGrace A. Lin
Grace A. Lin
TATimothy S. Anderson
Timothy S. Anderson

16 September 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
CHCallie Hlavin
Callie Hlavin
SMSruthi Muluk
Sruthi Muluk
VMVisala Muluk
Visala Muluk
JRJohn Ryan
John Ryan
JWJeffrey Wagner
Jeffrey Wagner
RDRajeev Dhupar
Rajeev Dhupar
Variability in surgeon prescribing patterns is common in the post-operative period and can be the nidus for dependence and addiction. This project aims to reduce opioid overprescribing at the Veteran’s Affairs Pittsburgh Healthcare System (VAPHS). The VAPHS Opioid Stewardship Committee collaborated to create prescribing guidelines for inpatient and outpatient general, thoracic, and vascular surgery procedures. We incorporated bundled order sets into the provider workflow in the electronic medical system and performed a retrospective cohort study comparing opioid prescription patterns for Veterans who underwent any surgical procedure for a three-month period pre- and post- guideline implementation. After implementation of opioid prescribing guidelines, morphine milligram equivalents (MME), quantity of pills prescribed, and days prescribed were statistically significantly reduced for procedures with associated guidelines, including cholecystectomy (MME 140.8 vs. 57.5, p = 0.002; quantity 18.8 vs. 8, p = 0.002; days 5.1 vs. 2.8, p = 0.021), inguinal hernia repair (MME 129.9 vs. 45.3, p = 0.002; quantity 17.3 vs. 6.1, p = 0.002; days 5.0 vs. 2.4, p = 0.002), and umbilical hernia repair (MME 128.8 vs. 53.8, p = 0.002; quantity 17.1 vs. 7.8, p = 0.002; days 5.1 vs. 2.5, p = 0.022). Procedures without associated recommendations also preceded a decrease in overall opioid prescribing. Post-operative opioid prescribing guidelines can steer clinicians toward more conscientious opioid disbursement. There may also be reductions in prescribing opioids for procedures without guidelines as an indirect effect of practice change.

1 April 2025 in JU Open Plus
Verified
Journal Article
Open access
SMSruthi L. Muluk
Sruthi L. Muluk
CDColeman Drake
Coleman Drake
ZSZhaojun Sun
Zhaojun Sun
MBManisha Bhattacharya
Manisha Bhattacharya
BJBruce L. Jacobs
Bruce L. Jacobs
LSLindsay M. Sabik
Lindsay M. Sabik
Purpose: For patients with muscle-invasive bladder cancer (MIBC), time to cystectomy and receipt of neoadjuvant chemotherapy are associated with improved survival. Travel burden may be an important barrier to timely guideline concordant treatment. Materials and Methods: We conducted a cross-sectional study of patients in Pennsylvania with a first lifetime cancer diagnosis of MIBC who underwent radical cystectomy at nonfederal short-term general hospitals identified in 2010 to 2016 Pennsylvania Cancer Registry linked to Pennsylvania Healthcare Cost Containment Council (PHC4) inpatient data through 2018. Physician location came from the Centers for Medicare and Medicaid Services. Results: Mean (SD) drive time to nearest oncologist was 17.1 (11.4) minutes and to nearest urologist was 13.9 (9.2) minutes. A 30-minute increase in drive time to the urologist was associated with a 12.5 percentage point lower likelihood of undergoing cystectomy within 90 days (95% confidence interval [CI]: −24.3 to −0.6), with greater effects for more socioeconomically disadvantaged areas (18.7 percentage point lower [95% CI: −33.1 to −4.3]). A 30-minute increase to the oncologist was associated with an 11.9 percentage point lower likelihood of receiving neoadjuvant chemotherapy (95% CI: −23.4 to −0.4). Drive time was not significantly associated with 90-day mortality or readmission. Conclusions: Drive time to oncologists and urologists is associated with timely receipt of guideline-recommended care for patients with MIBC. Understanding the impact of geographic access on clinical outcomes for patients with cancer who require multispecialty care can inform providers and policymakers in efforts to improve cancer care access and outcomes.

11 July 2024 in Journal of Minimally Invasive Gynecology
Verified
Journal Article
Closed access
NWNicole J. Wood
Nicole J. Wood
MKMadison R. Kasoff
Madison R. Kasoff
SMSruthi L. Muluk
Sruthi L. Muluk
RWRui Wang
Rui Wang
ETElena Tunitsky-Bitton
Elena Tunitsky-Bitton
ESElisabeth C. Sappenfield
Elisabeth C. Sappenfield